Lobbying disclosures · Lobbying report
NTRA: second_quarter 2026 lobbying report
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Follow NTRA- Became public
- Jul 10, 2026, 4:01 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 9, 2026, 5:29 PM EST
Why this is connected
Exact legal-name match: Natera, Inc. (https://www.sec.gov/Archives/edgar/data/1604821/).
Reported lobbying amounts
Expenses: $150,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/fad9c929-0df4-4fd4-94db-cbeedfd5c34e/","filing_uuid":"fad9c929-0df4-4fd4-94db-cbeedfd5c34e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/fad9c929-0df4-4fd4-94db-cbeedfd5c34e/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Todd Trautner","dt_posted":"2026-07-10T16:01:40-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"130111 McCallen Pass","registrant_address_2":"Suite 100 Building A","registrant_different_address":false,"registrant_city":"Austin","registrant_state":"TX","registrant_zip":"78753","registrant":{"id":401109130,"url":"https://lda.gov/api/v1/registrants/401109130/","house_registrant_id":66831,"name":"NATERA INC","description":null,"address_1":"130111 McCallen Pass","address_2":"Suite 100 Building A","address_3":null,"address_4":null,"city":"Austin","state":"TX","state_display":"Texas","zip":"78753","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TODD TRAUTNER","contact_telephone":"+1 216-832-2620","dt_updated":"2026-07-28T19:18:18.321261-04:00"},"client":{"id":64075,"url":"https://lda.gov/api/v1/clients/64075/","client_id":64075,"name":"NATERA INC","general_description":"health care testing and diagnostics company","client_government_entity":null,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148757,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"TRAUTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Price change after we could observe it
+2.51% NTRA
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in NTRA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 15, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Sep 22, 2025 · disclosed Oct 15, 2025 · Joint
- Sep 5, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Aug 22, 2025 · disclosed Sep 5, 2025 · Joint
- Aug 11, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 11, 2025 · Joint
- Dec 5, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Nov 20, 2024 · disclosed Dec 5, 2024 · Joint
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- May 4, 2021$1K–$15K
Sen. Bill Hagerty (R-TN)
$1K–$15K · Traded Apr 20, 2021 · disclosed May 4, 2021
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.